Clarivate Epidemiology’s coverage of acute heart failure (AHF) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the hospitalization rate of AHF…
Clarivate Epidemiology’s coverage of acute heart failure (AHF) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the hospitalization rate of AHF…
Clarivate Epidemiology’s coverage of coronary heart disease (CHD) comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and…
The primary goal of hemophilia A treatment is to prevent bleeding. Hemophilia A patients are a heterogeneous cohort; the tendency to bleed is highly individual. Currently available treatments…
MARKET OVERVIEWChronic hand eczema (CHE) is a painful and debilitating form of eczema localized to the hands that can seriously impact a patient’s quality of life. No prescription therapies are…
Clarivate’s Epidemiology’s coverage of pneumococcal vaccine comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States,…
Clarivate’s Epidemiology’s coverage of meningococcal ACWY vaccine comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States…
Clarivate’s Epidemiology’s coverage of influenza vaccine comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France,…
The oral type 2 diabetes (T2D) drug market is expected to grow, fueled by rising prevalence and an increasing aging population. Owing to the risk of proteinuria, cardiovascular (CV) complications,…